AxoGen, Inc. (NASDAQ:AXGN) CFO Peter J. Mariani purchased 3,333 shares of the company’s stock in a transaction that occurred on Friday, October 7th. The stock was bought at an average cost of $7.50 per share, for a total transaction of $24,997.50. Following the purchase, the chief financial officer now directly owns 3,333 shares in the company, valued at approximately $24,997.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of AxoGen, Inc. (NASDAQ:AXGN) opened at 8.72 on Monday. The company has a 50-day moving average of $8.74 and a 200-day moving average of $6.99. AxoGen, Inc. has a 1-year low of $4.08 and a 1-year high of $9.88. The firm’s market cap is $262.75 million.
AxoGen (NASDAQ:AXGN) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.09) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative return on equity of 193.60% and a negative net margin of 37.90%. Analysts predict that AxoGen, Inc. will post ($0.40) earnings per share for the current fiscal year.
Separately, Wedbush reissued an “outperform” rating and issued a $10.00 price target (up previously from $9.00) on shares of AxoGen in a research note on Thursday, August 4th.
Several large investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in AxoGen by 61.5% in the second quarter. Vanguard Group Inc. now owns 775,448 shares of the company’s stock valued at $5,335,000 after buying an additional 295,294 shares during the last quarter. BlackRock Fund Advisors increased its stake in AxoGen by 1,049.1% in the second quarter. BlackRock Fund Advisors now owns 634,132 shares of the company’s stock valued at $4,363,000 after buying an additional 578,948 shares during the last quarter. State Street Corp purchased a new stake in AxoGen during the second quarter valued at $1,885,000. BlackRock Institutional Trust Company N.A. increased its stake in AxoGen by 224.3% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 261,835 shares of the company’s stock valued at $1,801,000 after buying an additional 181,086 shares during the last quarter. Finally, Waddell & Reed Financial Inc. purchased a new stake in AxoGen during the second quarter valued at $1,371,000. 57.87% of the stock is owned by institutional investors and hedge funds.